EP Patent

EP4665732A1 — Salts and solid forms of elenestinib

Assigned to Assia Chemical Industries Ltd · Expires 2025-12-24 · 0y expired

What this patent protects

The present disclosure encompasses salts and solid-state forms of Elenestinib, processes for preparation thereof and pharmaceutical compositions thereof.

USPTO Abstract

The present disclosure encompasses salts and solid-state forms of Elenestinib, processes for preparation thereof and pharmaceutical compositions thereof.

Drugs covered by this patent

Patent Metadata

Patent number
EP4665732A1
Jurisdiction
EP
Classification
—
Expires
2025-12-24
Drug substance claim
No
Drug product claim
No
Assignee
Assia Chemical Industries Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.